Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Scientists Develop Technique that can Tell if Drugs Have Hit Their Target in the Human Body

Published: Monday, July 22, 2013
Last Updated: Monday, July 22, 2013
Bookmark and Share
The search for new drugs, including those for cancer, is set to speed up thanks to a new research technique invented by scientists at the Nanyang Technological University (NTU).

Named the “Cellular Thermal Shift Assay” (CETSA), scientists can now know for sure if a drug had reached its target protein in the body, which is a critical step in determining the effectiveness of most medicines.

Presently, scientists can only hypothesise if a drug has indeed reached its target protein, leading to expensive and prolonged drug development process. CETSA will help scientists take out much of the usual trial-and-error guesswork from the drug development equation.

This research breakthrough was recently published in Science, one of the world’s top scientific journals.

Most drugs operate by binding to one or more proteins, which ‘blocks’ the proteins’ function. Scientists around the world face two common bottlenecks: how to identify the right proteins to target and how to design drug molecules which are able to efficiently seek out and bind to these proteins.

CETSA’s inventor, Professor Pär Nordlund from NTU’s School of Biological Sciences, said their new method will not only ease the two bottlenecks, but also has important applications in monitoring a patient’s progress, for example, during cancer treatment.

“With CETSA, we can in principle determine which drug and treatment regime is most effective at targeting the proteins in the tumour in cancer patients, and monitor when resistance is developing,” says Prof Nordlund.

How CETSA works

When drugs react with target proteins in a cell, the proteins are able to withstand higher temperature before unfolding and precipitating, that is, turning solid. An example of protein precipitation is when liquid egg white (which is protein) is cooked (turning solid) at high heat.

“By heating protein samples and finding out which proteins are ‘cooked’ and which are left ‘uncooked’ due it being more heat resistant, we are able to know if the drugs had reached their target cells and if it had caused the desired binding to the proteins, blocking its functions,” added Prof Nordlund, who is also a Professor of Biophysics at the Karolinska Institutet, one of Europe's most prestigious medical universities, located in Sweden.

“With CETSA, costly and challenging drug development cycles can potentially be made more efficient, as the method can be used as a stringent control step at many phases of the process. Other methods are available for indirect measurements of drug binding but they are often less accurate, and CETSA will be a valuable tool to complement these technologies,” said the Swedish professor.

This project took Prof Nordlund’s team three years and they are now in the process of developing a prototype device. They are also in talks with pharmaceutical companies who are interested to collaborate in research.

Prof Nordlund is a leading structural biologist instrumental in establishing the laboratory of the Structural Genomics Consortium at Karolinska Institutet (Stockholm), and had received the prestigious Göran Gustafsson prize in chemistry from the Swedish Academy of Sciences in 2001.

He is also a member of the Nobel Assembly at the Karolinska Institutet and the Chemistry Class at the Swedish Academy of Science, as well as a Reviewing Editor at Science Magazine. In addition, he is the co-founder of three biotech companies Evitra Proteoma, Sprint Biosciences and Pelago Bioscience.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,700+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Antioxidants Cause Malignant Melanoma to Metastasize Faster
Fresh research at Sahlgrenska Academy has found that antioxidants can double the rate of melanoma metastasis in mice.
Have Your Drug Nano-Delivered Via Microbubble
A UC engineering professor is working to develop effective nanoparticle-bubble drug delivery systems to access precise locations in the body to treat medical conditions such as cancer, eye disease and spinal disc degeneration.
Enzyme Malfunction May be Why Binge Drinking Can Lead to Alcoholism
A new study in mice shows that restoring the synthesis of a key brain chemical tied to inhibiting addictive behavior may help prevent alcohol cravings following binge drinking.
Developing a Gel that Mimics Human Breast for Cancer Research
Scientists at the Universities of Manchester and Nottingham have been funded to develop a gel that will match many of the biological structures of human breast tissue, to advance cancer research and reduce animal testing.
Lung Repair and Regeneration Gene Discovered
New role for hedgehog gene offers better understanding of lung disease.
New Gene Therapy for Vision Loss From a Mitochondrial Disease
NIH-funded study shows success in targeting mitochondrial DNA in mice.
Self-Propelled Powder to Stop Bleeding
UBC researchers have created the first self-propelled particles capable of delivering coagulants against the flow of blood to treat severe bleeding, a potentially huge advancement in trauma care.
Tension Helps Heart Cells Develop Normally in the Lab
Stanford engineers have uncovered the important role tension plays in growing heart cells out of the body.
Controlling Body Temperature in Response to 'Fight or Flight'
New research in The FASEB Journal suggests that blocking TRPV1 protein causes an increased release of noradrenaline, leading to an increase in core body temperatures.
Inroads Against Leukaemia
Potential for halting disease in molecule isolated from sea sponges.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,700+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos